Haiwen Chen Selected Research

Haiwen Chen Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 06/2017 - 02/2006
10	Neoplasms (Cancer) 01/2023 - 09/2014
6	Epstein-Barr Virus Infections 01/2023 - 09/2019
3	Neoplasm Metastasis (Metastasis) 10/2022 - 10/2014
2	Demyelinating Diseases (Demyelinating Disease) 04/2024 - 11/2023
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
2	Carcinogenesis 03/2017 - 01/2015
1	Birth Weight (Birth Weights) 12/2023
1	Dementia (Dementias) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021
1	Disease Resistance 04/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2018
1	Kidney Neoplasms (Kidney Cancer) 10/2017
1	Shock 07/2017
1	Endometriosis 06/2017
1	Hypoxia (Hypoxemia) 12/2016
1	Carcinoma (Carcinomatosis) 12/2016
1	Colitis 12/2016
1	Autoimmune Diseases (Autoimmune Disease) 12/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Glioma (Gliomas) 10/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Inflammation (Inflammations) 06/2007
1	Leukocytosis (Pleocytosis) 06/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2016
3	VaccinesIBA 01/2022 - 01/2021
3	EpitopesIBA 01/2022 - 01/2021
2	Myelin-Oligodendrocyte GlycoproteinIBA 04/2024 - 11/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2014
2	Neutralizing AntibodiesIBA 01/2022 - 01/2022
2	phosphatidylinositol-3,4-bisphosphate 4-phosphataseIBA 06/2017 - 03/2017
2	Messenger RNA (mRNA)IBA 03/2017 - 12/2016
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 10/2014
2	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2013 - 06/2013
1	LipidsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	CateninsIBA 01/2023
1	CholesterolIBA 01/2023
1	EnzymesIBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	B7-H1 AntigenIBA 10/2022
1	PlatinumIBA 10/2022
1	eukaryotic initiation factor-5BIBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	AntigensIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Peptide LibraryIBA 01/2021
1	KinesinsIBA 12/2018
1	ORALIT (ORS)IBA 07/2018
1	CurcuminIBA 10/2017
1	PlacebosIBA 07/2017
1	Monoclonal AntibodiesIBA 06/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017
1	HLA-DR Antigens (HLA-DR)IBA 06/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2017
1	Cyclin D1IBA 03/2017
1	MicroRNAs (MicroRNA)IBA 03/2017
1	Netrin-1IBA 12/2016
1	Dextrans (Dextran)FDA Link 12/2016
1	Atorvastatin (Lipitor)FDA Link 12/2016
1	SodiumIBA 12/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016
1	ProstaglandinsIBA 05/2016
1	Oxidoreductases (Dehydrogenase)IBA 05/2016
1	AndrogensIBA 05/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Carrier Proteins (Binding Protein)IBA 01/2015
1	Notch ReceptorsIBA 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	ResveratrolIBA 10/2014
1	Aquaporin 5IBA 09/2014
1	Aquaporins (Water Channels)IBA 09/2014
1	Indicators and Reagents (Reagents)IBA 09/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2006

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2016
4	Immunotherapy 01/2023 - 01/2022
1	Length of Stay 12/2023
1	Long-Term Care 01/2023
1	Drug Therapy (Chemotherapy) 10/2022
1	Prostatectomy (Retropubic Prostatectomy) 06/2007